Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03476174
Title Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ralph Hauke
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Nebraska Cancer Specialists Omaha Nebraska 68114 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field